Wednesday, November 28, 2018 10:29:58 PM
(1) We just pulled our first Hemp Crop in Colorado
(2) Our Canadian Division - still surprised the board hasn’t discussed this. Hint: There’s a good reason we’re now in Canada.
(3) Louisiana coming online, revenue coming.
(4) We’re beginning blowing the TECO Trim into oil. Alone. 100% of that revenue will be booked by GBLX. The CURA License Deal is over, dead. This is a huge step for the ever so wanted “revenue”. Instead of a licensing deal we now receive 100% of that revenue.
(5) Another state where we’ll soon announce we’re the first licensed producer. Watch for the 8-K announcing this.
(6) At heart, the “moonshot” is Medicine. Making real pharmaceutical grade medicine which is why we grow in clean rooms utilizing tissue propagation. Our IP Portfolio is growing daily. Note the Clinical Study Dr Small Howard co-authored announced just last week. Once the stockholders voted on a larger A/S allotment was there ever any doubt we’d eventually reach it?
Lastly, you’re still using the wrong number for the float. It’s simple arithmetic. Pre recent Q float WAS 201 million. Recent Q announced 55 million warrants plus company self issued shares that were sold had been converted to shares. 201+ 55 equals 256. Simple arithmetic, the float is in the 256,000,000 range.
As for the statement “when and only when I see an updated plan..........perhaps you need to speak to the company, if you’ve tried and can’t get who you want on the phone perhaps that’s why you’re not aware of the list 1-6 above. It’s public knowledge, straight from the mans mouth.
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM